← FDA DRUG APPROVALS

FDA ANDA · ANDA078610

FLUDARABINE PHOSPHATE

Sponsor: ACTAVIS TOTOWA

APPLICATION
ANDA078610
TYPE
ANDA
ORIGINAL APPROVAL
2009-02-11
LATEST ACTION
2011-09-07
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

FLUDARABINE PHOSPHATEPrescription
FLUDARABINE PHOSPHATE 50MG/VIAL · INJECTABLE · INJECTION

Approval history

2011-09-07Labeling · Supplement 3AP
2010-05-24Labeling · Supplement 1AP
2009-02-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →